Don't miss our editorial board at the 2025 EURETINA Congress

Image credit: ©Milos – stock.adobe.com

Guess who is presenting at this year’s Congress of the European Society of Retina Specialists (EURETINA)? The editorial advisory boards of Ophthalmology Times, Modern Retina and Ophthalmology Times Europe. This year, 11 of our esteemed board members will be sharing their research findings—and a keynote lecture.

Add these presentations to your conference agenda today.

David Chow, MD

Ophthalmology Times editorial advisory board

Dr. Chow's vitreoretinal surgery ePoster, "The Safety, Brightness and Clinical Options of the LED RGB Light Source on the UNITY Vitreoretinal Cataract System (VCS) Platform," will be available to view in the poster terminals.

Burkhard Dick, MD, PhDOphthalmology Times Europe editorial advisory board

Prof. Burkhard Dick, a cataract and refractive specialist and secretary of the European Society of Cataract and Refractive Surgery (ESCRS), will co-chair a special joint session in the Grand Amphitheatre.

Saturday, 6 Sep

16:45 - 17:46 CEST

Euretina Session 12: Euretina / ESCRS Joint Symposium, Anterior Meets Posterior

David Eichenbaum, MD, FASRS

Ophthalmology Times editorial advisory board

Attendees may see Dr. Eichenbaum present on Friday.

Friday, 5 Sep

16:03 - 16:09 CEST

Structural Biomarkers Predicting Exudative AMD in GA: Results from a Real-World Data Study Using an AI-powered Research Platform

EURETINA Session 7: Results of Clinical Trials & Late Breaking News Session

Jean-Francois Korobelnik, MD

Modern Retina editorial advisory board

On Saturday, 6 Sep, 14:50 - 15:10 CEST, Prof. Korobelnik will deliver the Gisbert Richard Lecture, titled "Removal of intra-ocular foreign bodies: why, when, how?" At the end of the lecture, Prof. Anat Loewenstein, president of EURETINA, will present him with an award certificate.

He’ll also serve as chair, co-chair and speaker during other events.

Friday, 5 Sep

13:45 - 14:45 CEST

(Chair) Industry Satellite Symposium Session: From Data to Decisions: What Do We See in the Real World?

14:25 - 14:40 CEST

(Panelist) Clinical conversations: giving reassurance to “seize the day” in the real world

Industry Satellite Symposium Session: From Data to Decisions, What Do We See in the Real World?

Saturday, 6 Sep

11:30 - 12:30 CEST(Co-Chair) Cataract Surgery in Patients with Macular Disease: Practical Aspects on Indications and Treatment ResultsAdvanced instructional course

Anat Loewenstein, MD

Modern Retina editorial advisory board

Prof. Loewenstein will be very active during the conference, fulfilling her duties as the society’s president. She will also share several clinical presentations. For the full list, visit her page in the Congress program.

Friday, 5 Sep

12:15 - 13:15 CEST

Nonexudative AMD: Challenges in Disease Classification and Clinical Trial Endpoints Topic Advanced instructional course

Saturday, 6 Sep

10:53 - 11:01 CEST4-FRONT Protocol Part of Industry Satellite Sympoium Session, Intravitreal Gene Therapy: A New Era of Durable Treatment for Retinal Vascular Diseases with 4D-150

11:39 - 11:46 CEST

How should we monitor AMD?

Part of Recent Advances in the Management of AMD that are Changing our Clinical Practice

Alexandra Miere, MD, PhDOphthalmology Times Europe editorial advisory board

Dr Miere will have two ePosters at this year's Congress.

"Change in retinal perfusion with aflibercept for central retinal vein occlusion: the two-year prospective observational HERMES study" and "Can changes on OCTA predict exudative activity on OCT in eyes with neovascular age related macular degeneration? The ACTOR Study" will both be available for viewing in the poster terminals.

Quan Dong Nguyen, MD, MSc, FARVO, FASRS

Ophthalmology Times editorial advisory board

Prof. Nguyen will co-chair the following symposia.

Saturday, 6 Sep10:15 - 11:15 CEST

Industry Satellite Symposium Session: Photobiomodulation Therapy for Dry AMD: Insights from 4.5 Years of Follow-up from the LIGHTSITE IIIB Trial

Sunday, 7 Sep

11:30 - 12:30 CEST

Inherited Retinal Diseases and Uveitis: Co-Incidence or Co-Existence?

On Friday, 5 September, he will present a free paper titled “Comparative Evaluation of the Repeatability and Reproducibility of Manual and Novel Automated Methods for Measuring DAF and DDAF Lesions in Stargardt Disease.”

He will also share an ePoster, titled “The Burden of Treatment With Anti-Vascular Endothelial Growth Factor Injection on Patients and Health Care Professionals: A Qualitative Study.”

Tunde Peto, MD, PhDOphthalmology Times Europe editorial advisory board

Prof. Peto will serve as co-chair of the following events:

Friday, 5 Sep

08:30 - 09:30 CEST

Retinal Image Analysis: Preparing for the EBO-Euretina Exam-Imaging Section

Intermediate level instructional course

Saturday, 6 Sep

Saturday, 6 Sep

07:30 - 08:45 CEST

Women in Retina Networking Breakfast

09:00 - 10:00 CEST

Euretina Session 9 - Global Transformation of Disease Understanding and Management through Imaging: Are we Ready to Step into the Future?

Sunday, 7 Sep

09:00 - 10:00 CESTFree Paper Session 19, Imaging

11:30 - 12:30 CEST

Monitoring Brain Degeneration through Investigating the Eye

She will also serve as speaker at the following symposia:

Saturday, 6 Sep

12:30 - 12:36 CEST

Prevalent and incident macular fibrosis and macular atrophy in patients with neovascular aged macular degeneration treated with anti-vascular endothelial growth factor therapies

Part of Speakers’ Corner: AMD

14:47 - 14:57 CEST

Caring for the Carers: Emotional Intelligence in Caregiver Burden

Part of Still in the Loop: Sharpening the Human Skills AI Can’t Replace

Aleksandra Rachitskaya, MD

Modern Retina editorial advisory board

Dr Rachitskaya will co-chair “Challenging Retinal Surgical Videos Symposium by The Vit-Buckle Society,” on Friday, 5 Sep, 16:30 - 17:30 CEST.

She will also present on Friday, 5 September.

12:40 - 12:45 CEST

Combined Phaco-Vitrectomy: Should we be doing it more?

Part of VR Surgery: Who Says there’s No Evidence?

Rishi Singh, MDModern Retina editorial advisory board

Dr Singh will deliver two presentations, both on Friday.

Friday, 5 Sep

09:07 - 09:16 CEST

Switching and new drugs in non responders

Part of Identification and Management of Non-Responders in Neovascular AMD

10:03 - 10:09 CEST

Pooled functionality data of revakinagene taroretcel-lwey in patients with macular telangiectasia type 2Part of Speakers’ Corner

Charles C. Wykoff, MD, PhDModern Retina editorial advisory board

Dr Wykoff will present on three topics during the meeting. His e-poster, “A randomized, active-controlled clinical trial of fluocinolone acetonide 0.19 mg intravitreal implant for diabetic macular edema: Results of the NEW DAY study,” is also available for view.

Thursday, 4 Sep

15:00 - 15:09 CEST

Real-world Utilization Patterns & Outcomes with Anti-Complement Therapies for the Management of Geographic Atrophy

Part of Real-World Registries: Examples for Retinal Data Acquisition and Evaluation

Friday, 5 Sep

15:21 - 15:27 CEST

Bispecific trap-antibody inhibiting interleukin-6 and vascular endothelial growth factor (KSI-101): first-time results from the Phase 1b APEX Study in patients with macular edema secondary to inflammation (MESI)

Part of EURETINA Session 7 - Results of Clinical Trials & Late Breaking News Session

Saturday, 6 Sep

16:12 - 16:18 CEST

Ixoberogene soroparvovec intravitreal gene therapy for neovascular age-related macular degeneration (nAMD): Results from OPTIC and LUNA trials

Part of Speakers’ Corner: AMD